TMO Earnings Thermo Fisher Scientific
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Latest filing
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–60 of 60
| Q3 2026 | 2026-09-26 | 4.64 | 2026-10-30 | 10-Q |
| Q2 2026 | 2026-06-27 | 4.68 | 2026-07-31 | 10-Q |
| Q1 2026 | 2026-03-28 | 4.43 | 2026-05-01 | 10-Q |
| Q4 2025 (derived) | 2025-12-31 | 5.21 | 2026-02-26 | 10-K |
| FY 2025 | 2025-12-31 | 17.74 | 2026-02-26 | 10-K |
| Q3 2025 | 2025-09-27 | 4.27 | 2025-10-31 | 10-Q |
| Q2 2025 | 2025-06-28 | 4.28 | 2025-08-01 | 10-Q |
| Q1 2025 | 2025-03-29 | 3.98 | 2025-05-02 | 10-Q |
| Q4 2024 (derived) | 2024-12-31 | 4.78 | 2025-02-20 | 10-K |
| FY 2024 | 2024-12-31 | 16.53 | 2025-02-20 | 10-K |
| Q3 2024 | 2024-09-28 | 4.25 | 2024-11-01 | 10-Q |
| Q2 2024 | 2024-06-29 | 4.04 | 2024-08-02 | 10-Q |
| Q1 2024 | 2024-03-30 | 3.46 | 2024-05-03 | 10-Q |
| Q4 2023 (derived) | 2023-12-31 | 4.20 | 2024-02-22 | 10-K |
| FY 2023 | 2023-12-31 | 15.45 | 2024-02-22 | 10-K |
| Q3 2023 | 2023-09-30 | 4.42 | 2023-11-03 | 10-Q |
| Q2 2023 | 2023-07-01 | 3.51 | 2023-08-04 | 10-Q |
| Q1 2023 | 2023-04-01 | 3.32 | 2023-05-05 | 10-Q |
| Q4 2022 (derived) | 2022-12-31 | 4.01 | 2023-02-23 | 10-K |
| FY 2022 | 2022-12-31 | 17.63 | 2023-02-23 | 10-K |
| Q3 2022 | 2022-10-01 | 3.79 | 2022-11-04 | 10-Q |
| Q2 2022 | 2022-07-02 | 4.22 | 2022-08-05 | 10-Q |
| Q1 2022 | 2022-04-02 | 5.61 | 2022-05-06 | 10-Q |
| Q4 2021 (derived) | 2021-12-31 | 4.18 | 2022-02-24 | 10-K |
| FY 2021 | 2021-12-31 | 19.46 | 2022-02-24 | 10-K |
| Q3 2021 | 2021-10-02 | 4.79 | 2021-11-04 | 10-Q |
| Q2 2021 | 2021-07-03 | 4.61 | 2021-08-06 | 10-Q |
| Q1 2021 | 2021-04-03 | 5.88 | 2021-05-07 | 10-Q |
| Q4 2020 (derived) | 2020-12-31 | 6.25 | 2021-02-25 | 10-K |
| FY 2020 | 2020-12-31 | 15.96 | 2021-02-25 | 10-K |
| Q3 2020 | 2020-09-26 | 4.84 | 2020-10-30 | 10-Q |
| Q2 2020 | 2020-06-27 | 2.90 | 2020-07-31 | 10-Q |
| Q1 2020 | 2020-03-28 | 1.97 | 2020-05-01 | 10-Q |
| Q4 2019 | 2019-12-31 | 2.49 | 2020-02-26 | 10-K |
| FY 2019 | 2019-12-31 | 9.17 | 2020-02-26 | 10-K |
| Q3 2019 | 2019-09-28 | 1.88 | 2019-11-01 | 10-Q |
| Q2 2019 | 2019-06-29 | 2.77 | 2019-08-02 | 10-Q |
| Q1 2019 | 2019-03-30 | 2.02 | 2019-05-03 | 10-Q |
| Q4 2018 | 2018-12-31 | 2.22 | 2019-02-27 | 10-K |
| FY 2018 | 2018-12-31 | 7.24 | 2019-02-27 | 10-K |
| Q3 2018 | 2018-09-29 | 1.75 | 2018-11-02 | 10-Q |
| Q2 2018 | 2018-06-30 | 1.85 | 2018-08-03 | 10-Q |
| Q1 2018 | 2018-03-31 | 1.43 | 2018-05-04 | 10-Q |
| Q4 2017 | 2017-12-31 | 1.30 | 2018-02-28 | 10-K |
| FY 2017 | 2017-12-31 | 5.59 | 2018-02-28 | 10-K |
| Q3 2017 | 2017-09-30 | 1.34 | 2017-11-03 | 10-Q |
| Q2 2017 | 2017-07-01 | 1.56 | 2017-08-04 | 10-Q |
| Q1 2017 | 2017-04-01 | 1.40 | 2017-05-05 | 10-Q |
| Q4 2016 | 2016-12-31 | 1.59 | 2017-02-28 | 10-K |
| FY 2016 | 2016-12-31 | 5.09 | 2017-02-28 | 10-K |
| Q3 2016 | 2016-10-01 | 1.19 | 2016-11-04 | 10-Q |
| Q2 2016 | 2016-07-02 | 1.30 | 2016-08-05 | 10-Q |
| Q1 2016 | 2016-04-02 | 1.01 | 2016-05-06 | 10-Q |
| Q4 2015 | 2015-12-31 | 1.50 | 2016-02-25 | 10-K |
| FY 2015 | 2015-12-31 | 4.92 | 2016-02-25 | 10-K |
| Q3 2015 | 2015-09-26 | 1.18 | 2015-10-30 | 10-Q |
| Q2 2015 | 2015-06-27 | 1.27 | 2015-07-31 | 10-Q |
| Q1 2015 | 2015-03-28 | 0.96 | 2015-05-01 | 10-Q |
| Q4 2014 | 2014-12-31 | 1.49 | 2015-02-26 | 10-K |
| FY 2014 | 2014-12-31 | 4.71 | 2015-02-26 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Q4 EPS marked "derived" is computed as the fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive across quarters, so it can differ by a cent or two from the issuer's own Q4. A period with no "Reported" date is known only from a later filing's prior-year comparative. Informational only — not financial advice.